Siirry suoraan sisältöön
Radiation Oncology Advances
Tallenna

Radiation Oncology Advances

from combining radiation with a molecular targeted agent – namely cetuximab, a recombinant mouse/human chimeric monoclonal antibody against the Epidermal Growth Factor (EGF) receptor [4] Astsaturov, Cohen and Harari present a more indepth review of the biology of the EGF Receptor and its signaling pathway in Chap.
Painos
Softcover reprint of hardcover 1st ed. 2008
ISBN
9781441942210
Kieli
englanti
Paino
310 grammaa
Julkaisupäivä
29.11.2010
Sivumäärä
336